✦ LIBER ✦

Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors

✍ Scribed by T. Shah; W.K. Lai; D. Mutimer

Book ID: 110904029
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 107 KB
Volume: 7
Category: Article
ISSN: 1398-2273
DOI: 10.1111/j.1399-3062.2005.00093.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized controlled trial of oral ganc

Randomized controlled trial of oral ganciclovir versus intravenous ganciclovir for long-term prophylaxis of cytomegalovirus (CMV) disease in CMV-seronegative liver transplant recipients willi CMV-seropositive donors

✍ D. Winston; R.W. Busuttil 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 283 KB

Comparison of higher dose and lower dose

Comparison of higher dose and lower dose ganciclovir for cytomegalovirus prophylaxis in seropositive heart transplant recipients

✍ S.-O. Lee; J.H. Rim; H. Sung; S.-H. Kim; S.-H. Choi; C.W. Lee; T.J. Yun; J.-W. L 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Valganciclovir as preemptive therapy for

Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirus-seronegative liver transplant recipients of cytomegalovirus-seropositive donor allografts

✍ Nina Singh; Cheryl Wannstedt; Lois Keyes; Debra Mayher; Lisa Tickerhoof; Mohamed 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

The efficacy of valganciclovir as preemptive therapy for the prevention of cytomegalovirus (CMV) disease and its impact on indirect sequelae of CMV were assessed in recipient-negative/donor-positive (RϪ/Dϩ) liver transplant recipients. Of 187 consecutive liver transplant recipients at our institutio

Editorial: Oral Ganciclovir Usage for Cy

Editorial: Oral Ganciclovir Usage for Cytomegalovirus Prophylaxis in Organ Transplant Recipients: Is Emergence of Resistance Imminent?

✍ Nina Singh; Victor L. Yu 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 74 KB

A comparative randomised study of valacy

A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients

✍ I. D. Pavlopoulou; V. Ph. Syriopoulou; H. Chelioti; G. L. Daikos; D. Stamatiades 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Use of combination cytomegalovirus immun

Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: a multicenter, open-label study

✍ D.R Snydman; M.E Falagas; R Avery; C Perlino; R Ruthazer; R Freeman; R Rohrer; R 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 85 KB